Infliximab Product Information - Licensing Action

Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor Inc, Malvern, PA, License #1242
Expanded Indication for Use: Inhibition of progression of structural damage in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Approval Date: 12/29/2000
Type of submission: Biologics license supplement


Approval Letter (PDF) 

Label (PDF)

Page Last Updated: 04/06/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English